Triple Primary Malignancy Detection in an Elderly Male: A Case Report on Concurrent Prostate Cancer, Clear Cell Renal Cell Carcinoma, and Metastatic Melanoma Identified by PSMA PET-CT
Eylon J. Arbel , Brian F. Dinerman , John M. Rutkowski
{"title":"Triple Primary Malignancy Detection in an Elderly Male: A Case Report on Concurrent Prostate Cancer, Clear Cell Renal Cell Carcinoma, and Metastatic Melanoma Identified by PSMA PET-CT","authors":"Eylon J. Arbel , Brian F. Dinerman , John M. Rutkowski","doi":"10.1016/j.eucr.2024.102793","DOIUrl":null,"url":null,"abstract":"<div><p>We report the management of a 76-year-old male presenting with primary metastatic melanoma, prostatic carcinoma, and clear cell renal cell carcinoma. Each of the three cancers was identified via PSMA PET-CT, thought to be unique to prostate cancer identification. Management of this patient included axillary lymph node resection, radiation therapy, radical nephrectomy, and immunotherapy. This case emphasizes the need for a multimodal approach and a broad differential diagnosis when managing cancer patients. Furthermore, the full potential of PSMA PET-CT has yet to be established.</p></div>","PeriodicalId":38188,"journal":{"name":"Urology Case Reports","volume":"55 ","pages":"Article 102793"},"PeriodicalIF":0.5000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214442024001475/pdfft?md5=85eaca139c7b2df92078e32cbccbd449&pid=1-s2.0-S2214442024001475-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214442024001475","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
We report the management of a 76-year-old male presenting with primary metastatic melanoma, prostatic carcinoma, and clear cell renal cell carcinoma. Each of the three cancers was identified via PSMA PET-CT, thought to be unique to prostate cancer identification. Management of this patient included axillary lymph node resection, radiation therapy, radical nephrectomy, and immunotherapy. This case emphasizes the need for a multimodal approach and a broad differential diagnosis when managing cancer patients. Furthermore, the full potential of PSMA PET-CT has yet to be established.